Under fire over high prices, Eli Lilly promised cheaper insulin in 2019. The result has some lawmakers steamed.

Earlier this month, Sens. Elizabeth Warren (D-Mass.) and Richard Blumenthal (D-Conn.) surveyed 400 pharmacies and found a scarcity of the drug giant’s “authorized generic.”